(Q37411457)

20 August 2017

1 reference

title

Modular protein engineering in emerging cancer therapies (English)

1 reference

20 August 2017

Esther Vázquez

1

1 reference

20 August 2017

Neus Ferrer-Miralles

2

1 reference

20 August 2017

Ramón Mangues

3

1 reference

20 August 2017

José Luis Corchero

4

1 reference

20 August 2017

Simó Schwartz

5

1 reference

20 August 2017

Antonio Villaverde

6

1 reference

20 August 2017

publication date

1 January 2009

1 reference

Current Pharmaceutical Design

20 August 2017

published in

1 reference

20 August 2017

volume

15

1 reference

20 August 2017

issue

8

1 reference

20 August 2017

page(s)

893-916

1 reference

RNA interference-directed knockdown of urokinase plasminogen activator and urokinase plasminogen activator receptor inhibits prostate cancer cell invasion, survival, and tumorigenicity in vivo

20 August 2017

cites work

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1074/JBC.M503111200

Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer

1 reference

https://opencitations.net/index/api/v1/citations/10.1016/J.SURG.2004.04.029

COCI

reference URL

EphA2: a determinant of malignant cellular behavior and a potential therapeutic target in pancreatic adenocarcinoma

30 December 2023

1 reference

30 December 2023

https://opencitations.net/index/api/v1/citations/10.1038/SJ.ONC.1207247

Identifiers

DOI

10.2174/138161209787582084

1 reference

20 August 2017

1 reference